L
Lineage Cell Therapeutics Inc
XBER:BT3
Lineage Cell Therapeutics Inc
XBER:BT3
Price:
1.35
EUR
Market Closed
Market Cap:
€395.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lineage Cell Therapeutics Inc
XBER:BT3
|
US |
|
M
|
Meta Platforms Inc
XMUN:FB2A
|
US |
|
Vaxart Inc
NASDAQ:VXRT
|
US |
|
C
|
Commerzbank AG
F:ZZMS
|
DE |
|
P
|
Prudential PLC
OTC:PUKPF
|
UK |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
First Internet Bancorp
F:45H
|
US |
|
ALM Equity AB
F:I53
|
SE |
|
SOL SpA
F:QOL
|
IT |
|
Virgin Galactic Holdings Inc
F:0QL0
|
US |
|
M
|
Mitsui Chemicals Inc
DUS:MSI
|
JP |
|
Azienda Bresciana Petroli Nocivelli SpA
F:9UZ
|
IT |
|
V
|
Versigent PLC
NYSE:VGNT
|
CH |
|
V
|
Visteon Corp
XBER:VS51
|
US |
|
U
|
United Overseas Australia Ltd
SGX:EH5
|
MY |
|
C
|
Credit Suisse Group AG
XBER:CSX
|
CH |
|
Industrie De Nora SpA
LSE:0ABI
|
IT |
|
S
|
Stora Enso Oyj
XMUN:ENUR
|
FI |
|
Dynatrace Inc
NYSE:DT
|
US |
|
A
|
Asahi Kasei Corp
DUS:ASAA
|
JP |
|
Plexus Corp
F:PX4
|
US |
|
Angi Inc
F:2UH0
|
US |
|
M
|
Meta Platforms Inc
DUS:FB2A
|
US |
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
DCF Valuation
is not available for Lineage Cell Therapeutics Inc
is not available for Lineage Cell Therapeutics Inc
BT3's DCF value cannot be reliably calculated.
Switch to
See Also
Other Lineage Cell Therapeutics Inc listings:
Discover More
